Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Promising New Developments in the Fight Against Cancer From SHAL Technologies

Biotech Awarded NIH Grant to Continue Testing New Drugs to Treat Lymphomas and Leukemias LIVERMORE, CA–(Marketwired – April 21, 2015) – SHAL Technologies, an emerging biotech company in the San Francisco Bay Area, has been awarded a $1.5M Phase II SBIR grant by the National Cancer Institute of NIH to complete the preclinical testing of […]

Read More »

Seattle Children’s Pediatric Leukemia Adoptive Therapy (PLAT-02) Clinical Trial Boasts 91% Complete Remission Rate in Children with Relapsed Leukemia

SEATTLE, April 21, 2015 /PRNewswire/ — Seattle Children’s announced today that 20 of 22 patients treated thus far in a clinical trial using genetically reprogrammed T cells to treat relapsed acute lymphoblastic leukemia (ALL) have achieved complete remission, confirmed by highly sensitive tests designed to detect minute amounts of cancer cells. The 20 patients who […]

Read More »

Stroke Risk Caused by Abnormal Heart Rhythm Reduced Without Blood Thinners

DETROIT, April 21, 2015 /PRNewswire/ — Cardiologists at Henry Ford Hospital have implanted a device that reduces the risk of stroke in patients with an irregular heartbeat. With only handful of hospitals in the Midwest offering this procedure, Henry Ford is able to add another option to its arsenal of tools for certain patients with […]

Read More »

MMR Vaccine and Autism: Yet Again, No Link Exists – Even For Children At Risk For Autism

You might have thought scientists were done studying the MMR (measles mumps rubella) vaccine and autism. After all, numerous studies show no link between the two. But the anti-vaccine advocates who cling to the falsehood that any link might exist have frequently moved the goalposts, and one of their arguments is that the vaccine might […]

Read More »

First infant MRI study finds babies feel pain ‘like adults’

(Reuters) – The brains of babies “light up” in a similar way to adults when exposed to the same painful stimulus, suggesting they feel pain much like adults do, researchers said on Tuesday. In the first of its kind study using magnetic resonance imaging (MRI), scientists from Britain’s Oxford University found that 18 of the […]

Read More »

Sexual dysfunction may accompany PTSD

(Reuters Health) – Men and women with post-traumatic stress disorder (PTSD) may also experience sexual dysfunction and relationship difficulties, a new research review suggests. “Persons with PTSD often complain of sexual dysfunction and problems with intimacy more generally,” and there’s increasing evidence to support this association, said lead study author Rachel Yehuda in an email. […]

Read More »

Protein identified that serves as a “break” on inflammation

MEMPHIS, Tenn., April 21, 2015 /PRNewswire-USNewswire/ — Researchers have identified a protein that offers a new focus for developing targeted therapies to tame the severe inflammation associated with multiple sclerosis (MS), colitis and other autoimmune disorders. St. Jude Children’s Research Hospital scientists led the study which appears today in the scientific journal Immunity. Investigators showed that […]

Read More »

In Historic First, San Francisco Board of Supervisors Votes to Take Tobacco Out of Baseball

SAN FRANCISCO, April 21, 2015 /PRNewswire-USNewswire/ — Today the San Francisco Board of Supervisors unanimously passed an ordinance to prohibit use of all tobacco products – including smokeless tobacco – at all baseball venues and athletic fields within the city and county of San Francisco, including by fans and players at AT&T Park. San Francisco […]

Read More »

Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-Oncology Therapeutics

TOKYO and CAMBRIDGE, Mass., April 21, 2015 /PRNewswire/ — Astellas Pharma Inc. (Tokyo: 4503) and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, today announced an exclusive research and development collaboration.  The goal of the collaboration is to advance a portfolio consisting of programs with novel mechanisms of action targeting immune checkpoint […]

Read More »

Cantrixil Receives Orphan Drug Designation from FDA

SYDNEY, April 21, 2015 /PRNewswire/ — US-Australian drug discovery company, Novogen, today announced that its subsidiary joint venture company with Yale University, CanTx, Inc, has today received notification from the U.S. Food and Drug Administration (FDA) that its chemotherapy candidate drug, Cantrixil, has been granted Orphan Drug Designation for ovarian cancer. Orphan Drug Designation is an important […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom